Shopping Cart 0
Cart Subtotal
USD 0

Global Nuclear Medicine or Radiopharmaceuticals Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3400

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 6200

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6200

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 6200

Details

The Nuclear Medicine or Radiopharmaceuticals market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Nuclear Medicine or Radiopharmaceuticals market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Nuclear Medicine or Radiopharmaceuticals market. The report focuses on well-known providers in the global Nuclear Medicine or Radiopharmaceuticals industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Nuclear Medicine or Radiopharmaceuticals Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Nuclear Medicine or Radiopharmaceuticals market covered in Chapter 4:

Nordion

GE Healthcare

Mallinckrodt PLC

Advanced Accelerator Applications S.A.

Bayer Healthcare

Eczcibasi-Monrol Nuclear Products

Cardinal Health

IBA Molecular Imaging

Bracco Imaging S.P.A

Lantheus Medical Imaging

In Chapter 11 and 13.3, on the basis of types, the Nuclear Medicine or Radiopharmaceuticals market from 2015 to 2026 is primarily split into:

Diagnosis

Therapeutics

In Chapter 12 and 13.4, on the basis of applications, the Nuclear Medicine or Radiopharmaceuticals market from 2015 to 2026 covers:

Alpha radiation therapy

Beta radiation therapy

Brachytherapy

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

READ MORE

Table Of Content

Scope

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Nuclear Medicine or Radiopharmaceuticals Market Share by Type (2020-2026)

1.5.2 Diagnosis

1.5.3 Therapeutics

1.6 Market by Application

1.6.1 Global Nuclear Medicine or Radiopharmaceuticals Market Share by Application (2020-2026)

1.6.2 Alpha radiation therapy

1.6.3 Beta radiation therapy

1.6.4 Brachytherapy

1.7 Nuclear Medicine or Radiopharmaceuticals Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 Porter s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Nuclear Medicine or Radiopharmaceuticals Market

3.1 Value Chain Status

3.2 Nuclear Medicine or Radiopharmaceuticals Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Nuclear Medicine or Radiopharmaceuticals

3.2.3 Labor Cost of Nuclear Medicine or Radiopharmaceuticals

3.2.3.1 Labor Cost of Nuclear Medicine or Radiopharmaceuticals Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Nordion

4.1.1 Nordion Basic Information

4.1.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.1.3 Nordion Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.1.4 Nordion Business Overview

4.2 GE Healthcare

4.2.1 GE Healthcare Basic Information

4.2.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.2.3 GE Healthcare Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.2.4 GE Healthcare Business Overview

4.3 Mallinckrodt PLC

4.3.1 Mallinckrodt PLC Basic Information

4.3.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.3.3 Mallinckrodt PLC Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.3.4 Mallinckrodt PLC Business Overview

4.4 Advanced Accelerator Applications S.A.

4.4.1 Advanced Accelerator Applications S.A. Basic Information

4.4.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.4.3 Advanced Accelerator Applications S.A. Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.4.4 Advanced Accelerator Applications S.A. Business Overview

4.5 Bayer Healthcare

4.5.1 Bayer Healthcare Basic Information

4.5.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.5.3 Bayer Healthcare Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.5.4 Bayer Healthcare Business Overview

4.6 Eczcibasi-Monrol Nuclear Products

4.6.1 Eczcibasi-Monrol Nuclear Products Basic Information

4.6.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.6.3 Eczcibasi-Monrol Nuclear Products Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.6.4 Eczcibasi-Monrol Nuclear Products Business Overview

4.7 Cardinal Health

4.7.1 Cardinal Health Basic Information

4.7.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.7.3 Cardinal Health Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.7.4 Cardinal Health Business Overview

4.8 IBA Molecular Imaging

4.8.1 IBA Molecular Imaging Basic Information

4.8.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.8.3 IBA Molecular Imaging Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.8.4 IBA Molecular Imaging Business Overview

4.9 Bracco Imaging S.P.A

4.9.1 Bracco Imaging S.P.A Basic Information

4.9.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.9.3 Bracco Imaging S.P.A Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.9.4 Bracco Imaging S.P.A Business Overview

4.10 Lantheus Medical Imaging

4.10.1 Lantheus Medical Imaging Basic Information

4.10.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.10.3 Lantheus Medical Imaging Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.10.4 Lantheus Medical Imaging Business Overview

5 Global Nuclear Medicine or Radiopharmaceuticals Market Analysis by Regions

5.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Regions

5.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales by Regions (2015-2020)

5.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue by Regions (2015-2020)

5.2 North America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

5.3 Europe Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

5.6 South America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6 North America Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

6.1 North America Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

6.1.1 North America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

6.1.2 North America Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

6.1.3 North America Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

6.2 United States Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6.2.1 United States Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

6.3 Canada Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6.4 Mexico Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7 Europe Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

7.1 Europe Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

7.1.1 Europe Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

7.1.2 Europe Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

7.1.3 Europe Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.2 Germany Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.2.1 Germany Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.3 UK Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.3.1 UK Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.4 France Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.4.1 France Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.5 Italy Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.5.1 Italy Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.6 Spain Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.6.1 Spain Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.7 Russia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.7.1 Russia Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

8.1 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.2 China Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.2.1 China Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.3 Japan Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.3.1 Japan Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.4 South Korea Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.4.1 South Korea Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.5 Australia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.6 India Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.6.1 India Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.7 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

9 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

9.1 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

9.2 Saudi Arabia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.3 UAE Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.4 Egypt Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.5 Nigeria Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.6 South Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10 South America Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

10.1 South America Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

10.1.1 South America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

10.1.2 South America Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

10.1.3 South America Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

10.2 Brazil Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.2.1 Brazil Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

10.3 Argentina Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.4 Columbia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.5 Chile Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

11 Global Nuclear Medicine or Radiopharmaceuticals Market Segment by Types

11.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales and Market Share by Types (2015-2020)

11.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share by Types (2015-2020)

11.2 Diagnosis Sales and Price (2015-2020)

11.3 Therapeutics Sales and Price (2015-2020)

12 Global Nuclear Medicine or Radiopharmaceuticals Market Segment by Applications

12.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales and Market Share by Applications (2015-2020)

12.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share by Applications (2015-2020)

12.2 Alpha radiation therapy Sales, Revenue and Growth Rate (2015-2020)

12.3 Beta radiation therapy Sales, Revenue and Growth Rate (2015-2020)

12.4 Brachytherapy Sales, Revenue and Growth Rate (2015-2020)

13 Nuclear Medicine or Radiopharmaceuticals Market Forecast by Regions (2020-2026)

13.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Growth Rate (2020-2026)

13.2 Nuclear Medicine or Radiopharmaceuticals Market Forecast by Regions (2020-2026)

13.2.1 North America Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.2.2 Europe Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.2.3 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.2.4 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.2.5 South America Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.3 Nuclear Medicine or Radiopharmaceuticals Market Forecast by Types (2020-2026)

13.4 Nuclear Medicine or Radiopharmaceuticals Market Forecast by Applications (2020-2026)

13.5 Nuclear Medicine or Radiopharmaceuticals Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source


List Of Figure

List of Tables and Figures

Table Global Nuclear Medicine or Radiopharmaceuticals Market Size Growth Rate by Type (2020-2026)

Figure Global Nuclear Medicine or Radiopharmaceuticals Market Share by Type in 2019 & 2026

Figure Diagnosis Features

Figure Therapeutics Features

Table Global Nuclear Medicine or Radiopharmaceuticals Market Size Growth by Application (2020-2026)

Figure Global Nuclear Medicine or Radiopharmaceuticals Market Share by Application in 2019 & 2026

Figure Alpha radiation therapy Description

Figure Beta radiation therapy Description

Figure Brachytherapy Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global Nuclear Medicine or Radiopharmaceuticals Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of Nuclear Medicine or Radiopharmaceuticals

Figure Production Process of Nuclear Medicine or Radiopharmaceuticals

Figure Manufacturing Cost Structure of Nuclear Medicine or Radiopharmaceuticals

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table Nordion Profile

Table Nordion Production, Value, Price, Gross Margin 2015-2020

Table GE Healthcare Profile

Table GE Healthcare Production, Value, Price, Gross Margin 2015-2020

Table Mallinckrodt PLC Profile

Table Mallinckrodt PLC Production, Value, Price, Gross Margin 2015-2020

Table Advanced Accelerator Applications S.A. Profile

Table Advanced Accelerator Applications S.A. Production, Value, Price, Gross Margin 2015-2020

Table Bayer Healthcare Profile

Table Bayer Healthcare Production, Value, Price, Gross Margin 2015-2020

Table Eczcibasi-Monrol Nuclear Products Profile

Table Eczcibasi-Monrol Nuclear Products Production, Value, Price, Gross Margin 2015-2020

Table Cardinal Health Profile

Table Cardinal Health Production, Value, Price, Gross Margin 2015-2020

Table IBA Molecular Imaging Profile

Table IBA Molecular Imaging Production, Value, Price, Gross Margin 2015-2020

Table Bracco Imaging S.P.A Profile

Table Bracco Imaging S.P.A Production, Value, Price, Gross Margin 2015-2020

Table Lantheus Medical Imaging Profile

Table Lantheus Medical Imaging Production, Value, Price, Gross Margin 2015-2020

Figure Global Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales by Regions (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Regions (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Regions (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions in 2015

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions in 2019

Figure North America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table North America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table North America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Figure North America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2015

Figure North America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2019

Table North America Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table North America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure United States Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Canada Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Mexico Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) Growth (2015-2020)

Table Europe Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table Europe Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2015

Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2019

Table Europe Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table Europe Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure Germany Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure UK Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure France Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Italy Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Spain Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Russia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2015

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2019

Table Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure China Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Japan Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South Korea Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Australia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure India Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure Saudi Arabia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure UAE Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Egypt Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Nigeria Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table South America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table South America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table South America Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table South America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure Brazil Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Argentina Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Columbia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Chile Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales by Types (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Share by Types (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Types (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Share by Types (2015-2020)

Figure Global Diagnosis Sales and Growth Rate (2015-2020)

Figure Global Diagnosis Price (2015-2020)

Figure Global Therapeutics Sales and Growth Rate (2015-2020)

Figure Global Therapeutics Price (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales by Applications (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Share by Applications (2015-2020)

Figure Global Alpha radiation therapy Sales and Growth Rate (2015-2020)

Figure Global Alpha radiation therapy Revenue and Growth Rate (2015-2020)

Figure Global Beta radiation therapy Sales and Growth Rate (2015-2020)

Figure Global Beta radiation therapy Revenue and Growth Rate (2015-2020)

Figure Global Brachytherapy Sales and Growth Rate (2015-2020)

Figure Global Brachytherapy Revenue and Growth Rate (2015-2020)

Figure Global Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2020-2026)

Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth Rate (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Forecast by Regions (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Forecast by Regions (2020-2026)

Figure North America Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Figure South America Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Forecast by Types (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Market Share Forecast by Types (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Forecast by Types (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share Forecast by Types (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Forecast by Applications (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Market Share Forecast by Applications (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Forecast by Applications (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share Forecast by Applications (2020-2026)

Licence Rights

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The Nuclear Medicine or Radiopharmaceuticals market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Nuclear Medicine or Radiopharmaceuticals market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Nuclear Medicine or Radiopharmaceuticals market. The report focuses on well-known providers in the global Nuclear Medicine or Radiopharmaceuticals industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Nuclear Medicine or Radiopharmaceuticals Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Nuclear Medicine or Radiopharmaceuticals market covered in Chapter 4:

Nordion

GE Healthcare

Mallinckrodt PLC

Advanced Accelerator Applications S.A.

Bayer Healthcare

Eczcibasi-Monrol Nuclear Products

Cardinal Health

IBA Molecular Imaging

Bracco Imaging S.P.A

Lantheus Medical Imaging

In Chapter 11 and 13.3, on the basis of types, the Nuclear Medicine or Radiopharmaceuticals market from 2015 to 2026 is primarily split into:

Diagnosis

Therapeutics

In Chapter 12 and 13.4, on the basis of applications, the Nuclear Medicine or Radiopharmaceuticals market from 2015 to 2026 covers:

Alpha radiation therapy

Beta radiation therapy

Brachytherapy

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

READ MORE

Scope

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Nuclear Medicine or Radiopharmaceuticals Market Share by Type (2020-2026)

1.5.2 Diagnosis

1.5.3 Therapeutics

1.6 Market by Application

1.6.1 Global Nuclear Medicine or Radiopharmaceuticals Market Share by Application (2020-2026)

1.6.2 Alpha radiation therapy

1.6.3 Beta radiation therapy

1.6.4 Brachytherapy

1.7 Nuclear Medicine or Radiopharmaceuticals Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 Porter s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Nuclear Medicine or Radiopharmaceuticals Market

3.1 Value Chain Status

3.2 Nuclear Medicine or Radiopharmaceuticals Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Nuclear Medicine or Radiopharmaceuticals

3.2.3 Labor Cost of Nuclear Medicine or Radiopharmaceuticals

3.2.3.1 Labor Cost of Nuclear Medicine or Radiopharmaceuticals Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Nordion

4.1.1 Nordion Basic Information

4.1.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.1.3 Nordion Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.1.4 Nordion Business Overview

4.2 GE Healthcare

4.2.1 GE Healthcare Basic Information

4.2.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.2.3 GE Healthcare Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.2.4 GE Healthcare Business Overview

4.3 Mallinckrodt PLC

4.3.1 Mallinckrodt PLC Basic Information

4.3.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.3.3 Mallinckrodt PLC Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.3.4 Mallinckrodt PLC Business Overview

4.4 Advanced Accelerator Applications S.A.

4.4.1 Advanced Accelerator Applications S.A. Basic Information

4.4.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.4.3 Advanced Accelerator Applications S.A. Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.4.4 Advanced Accelerator Applications S.A. Business Overview

4.5 Bayer Healthcare

4.5.1 Bayer Healthcare Basic Information

4.5.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.5.3 Bayer Healthcare Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.5.4 Bayer Healthcare Business Overview

4.6 Eczcibasi-Monrol Nuclear Products

4.6.1 Eczcibasi-Monrol Nuclear Products Basic Information

4.6.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.6.3 Eczcibasi-Monrol Nuclear Products Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.6.4 Eczcibasi-Monrol Nuclear Products Business Overview

4.7 Cardinal Health

4.7.1 Cardinal Health Basic Information

4.7.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.7.3 Cardinal Health Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.7.4 Cardinal Health Business Overview

4.8 IBA Molecular Imaging

4.8.1 IBA Molecular Imaging Basic Information

4.8.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.8.3 IBA Molecular Imaging Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.8.4 IBA Molecular Imaging Business Overview

4.9 Bracco Imaging S.P.A

4.9.1 Bracco Imaging S.P.A Basic Information

4.9.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.9.3 Bracco Imaging S.P.A Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.9.4 Bracco Imaging S.P.A Business Overview

4.10 Lantheus Medical Imaging

4.10.1 Lantheus Medical Imaging Basic Information

4.10.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification

4.10.3 Lantheus Medical Imaging Nuclear Medicine or Radiopharmaceuticals Market Performance (2015-2020)

4.10.4 Lantheus Medical Imaging Business Overview

5 Global Nuclear Medicine or Radiopharmaceuticals Market Analysis by Regions

5.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Regions

5.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales by Regions (2015-2020)

5.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue by Regions (2015-2020)

5.2 North America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

5.3 Europe Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

5.6 South America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6 North America Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

6.1 North America Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

6.1.1 North America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

6.1.2 North America Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

6.1.3 North America Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

6.2 United States Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6.2.1 United States Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

6.3 Canada Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6.4 Mexico Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7 Europe Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

7.1 Europe Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

7.1.1 Europe Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

7.1.2 Europe Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

7.1.3 Europe Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.2 Germany Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.2.1 Germany Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.3 UK Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.3.1 UK Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.4 France Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.4.1 France Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.5 Italy Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.5.1 Italy Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.6 Spain Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.6.1 Spain Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

7.7 Russia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.7.1 Russia Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

8.1 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.2 China Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.2.1 China Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.3 Japan Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.3.1 Japan Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.4 South Korea Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.4.1 South Korea Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.5 Australia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.6 India Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.6.1 India Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

8.7 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

9 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

9.1 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

9.2 Saudi Arabia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.3 UAE Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.4 Egypt Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.5 Nigeria Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.6 South Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10 South America Nuclear Medicine or Radiopharmaceuticals Market Analysis by Countries

10.1 South America Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Countries

10.1.1 South America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

10.1.2 South America Nuclear Medicine or Radiopharmaceuticals Revenue by Countries (2015-2020)

10.1.3 South America Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

10.2 Brazil Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.2.1 Brazil Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19

10.3 Argentina Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.4 Columbia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.5 Chile Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

11 Global Nuclear Medicine or Radiopharmaceuticals Market Segment by Types

11.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales and Market Share by Types (2015-2020)

11.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share by Types (2015-2020)

11.2 Diagnosis Sales and Price (2015-2020)

11.3 Therapeutics Sales and Price (2015-2020)

12 Global Nuclear Medicine or Radiopharmaceuticals Market Segment by Applications

12.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales and Market Share by Applications (2015-2020)

12.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share by Applications (2015-2020)

12.2 Alpha radiation therapy Sales, Revenue and Growth Rate (2015-2020)

12.3 Beta radiation therapy Sales, Revenue and Growth Rate (2015-2020)

12.4 Brachytherapy Sales, Revenue and Growth Rate (2015-2020)

13 Nuclear Medicine or Radiopharmaceuticals Market Forecast by Regions (2020-2026)

13.1 Global Nuclear Medicine or Radiopharmaceuticals Sales, Revenue and Growth Rate (2020-2026)

13.2 Nuclear Medicine or Radiopharmaceuticals Market Forecast by Regions (2020-2026)

13.2.1 North America Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.2.2 Europe Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.2.3 Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.2.4 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.2.5 South America Nuclear Medicine or Radiopharmaceuticals Market Forecast (2020-2026)

13.3 Nuclear Medicine or Radiopharmaceuticals Market Forecast by Types (2020-2026)

13.4 Nuclear Medicine or Radiopharmaceuticals Market Forecast by Applications (2020-2026)

13.5 Nuclear Medicine or Radiopharmaceuticals Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source


List Of Figure

List of Tables and Figures

Table Global Nuclear Medicine or Radiopharmaceuticals Market Size Growth Rate by Type (2020-2026)

Figure Global Nuclear Medicine or Radiopharmaceuticals Market Share by Type in 2019 & 2026

Figure Diagnosis Features

Figure Therapeutics Features

Table Global Nuclear Medicine or Radiopharmaceuticals Market Size Growth by Application (2020-2026)

Figure Global Nuclear Medicine or Radiopharmaceuticals Market Share by Application in 2019 & 2026

Figure Alpha radiation therapy Description

Figure Beta radiation therapy Description

Figure Brachytherapy Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global Nuclear Medicine or Radiopharmaceuticals Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of Nuclear Medicine or Radiopharmaceuticals

Figure Production Process of Nuclear Medicine or Radiopharmaceuticals

Figure Manufacturing Cost Structure of Nuclear Medicine or Radiopharmaceuticals

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table Nordion Profile

Table Nordion Production, Value, Price, Gross Margin 2015-2020

Table GE Healthcare Profile

Table GE Healthcare Production, Value, Price, Gross Margin 2015-2020

Table Mallinckrodt PLC Profile

Table Mallinckrodt PLC Production, Value, Price, Gross Margin 2015-2020

Table Advanced Accelerator Applications S.A. Profile

Table Advanced Accelerator Applications S.A. Production, Value, Price, Gross Margin 2015-2020

Table Bayer Healthcare Profile

Table Bayer Healthcare Production, Value, Price, Gross Margin 2015-2020

Table Eczcibasi-Monrol Nuclear Products Profile

Table Eczcibasi-Monrol Nuclear Products Production, Value, Price, Gross Margin 2015-2020

Table Cardinal Health Profile

Table Cardinal Health Production, Value, Price, Gross Margin 2015-2020

Table IBA Molecular Imaging Profile

Table IBA Molecular Imaging Production, Value, Price, Gross Margin 2015-2020

Table Bracco Imaging S.P.A Profile

Table Bracco Imaging S.P.A Production, Value, Price, Gross Margin 2015-2020

Table Lantheus Medical Imaging Profile

Table Lantheus Medical Imaging Production, Value, Price, Gross Margin 2015-2020

Figure Global Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales by Regions (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Regions (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Regions (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions in 2015

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Regions in 2019

Figure North America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South America Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table North America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table North America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Figure North America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2015

Figure North America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2019

Table North America Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table North America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure United States Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Canada Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Mexico Nuclear Medicine or Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) Growth (2015-2020)

Table Europe Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table Europe Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2015

Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2019

Table Europe Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table Europe Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure Germany Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure UK Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure France Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Italy Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Spain Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Russia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2015

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries in 2019

Table Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure China Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Japan Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South Korea Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Australia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure India Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure Saudi Arabia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure UAE Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Egypt Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Nigeria Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South Africa Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth (2015-2020)

Table South America Nuclear Medicine or Radiopharmaceuticals Sales by Countries (2015-2020)

Table South America Nuclear Medicine or Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table South America Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Countries (2015-2020)

Table South America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2015

Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Countries in 2019

Figure Brazil Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Argentina Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Columbia Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Chile Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales by Types (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Share by Types (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) by Types (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Share by Types (2015-2020)

Figure Global Diagnosis Sales and Growth Rate (2015-2020)

Figure Global Diagnosis Price (2015-2020)

Figure Global Therapeutics Sales and Growth Rate (2015-2020)

Figure Global Therapeutics Price (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales by Applications (2015-2020)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Share by Applications (2015-2020)

Figure Global Alpha radiation therapy Sales and Growth Rate (2015-2020)

Figure Global Alpha radiation therapy Revenue and Growth Rate (2015-2020)

Figure Global Beta radiation therapy Sales and Growth Rate (2015-2020)

Figure Global Beta radiation therapy Revenue and Growth Rate (2015-2020)

Figure Global Brachytherapy Sales and Growth Rate (2015-2020)

Figure Global Brachytherapy Revenue and Growth Rate (2015-2020)

Figure Global Nuclear Medicine or Radiopharmaceuticals Sales and Growth Rate (2020-2026)

Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (USD ) and Growth Rate (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Forecast by Regions (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Forecast by Regions (2020-2026)

Figure North America Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure North America Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure Europe Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure Asia-Pacific Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Figure South America Nuclear Medicine or Radiopharmaceuticals Sales Forecast (2020-2026)

Figure South America Nuclear Medicine or Radiopharmaceuticals Revenue Forecast (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Forecast by Types (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Market Share Forecast by Types (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Forecast by Types (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share Forecast by Types (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Forecast by Applications (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Sales Market Share Forecast by Applications (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Forecast by Applications (2020-2026)

Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share Forecast by Applications (2020-2026)

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS